We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Roche and Alnylam Form Major Alliance on RNAi Therapeutics

News   Jul 09, 2007

 
Roche and Alnylam Form Major Alliance on RNAi Therapeutics
 
 
 

RELATED ARTICLES

Novel Synthesis Strategy Speeds Up Identification of Simpler Versions of Natural Product

News

A new chemical synthesis strategy to harvest the rich information found in natural products has led to the identification of novel, simpler derivatives with potential to selectively protect neurons, important for neurodegenerative diseases like Alzheimer’s disease, or to prevent the body’s immune system from rejecting organ transplants, according to a Baylor University-led study.

READ MORE

Scientists Crack the Chemical Code of Complex “Anti-tumor Antibiotic”

News

After 20 years of dedicated research, scientists have cracked the chemical code of an incredibly complex "anti-tumor antibiotic" known to be highly effective against cancer cells as well as drug-resistant bacteria, and have reproduced it synthetically in the lab for the first time.

READ MORE

Cellular Drivers of Painful Childhood Food Allergy Characterized

News

An eight-year hunt for the cells that drive an extreme childhood food allergy (eosinophilic esophagitis, EoE) has identified a potential new way to treat the disease while also raising questions about a dietary supplement often taken to reduce bowel inflammation.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE